Interstitial Lung Disease

Progressive fibrosing interstitial lung disease was associated with poorer survival in patients with connective tissue disease-associated ILDs, according to new results published in Respiratory Medicine.

Individuals with preexisting respiratory diseases, including asthma and COPD, had a modestly increased risk for severe COVID-19 infection, researchers reported in The Lancet Respiratory Medicine.

Although immunosuppressives remain the cornerstone for managing underlying interstitial lung disease in connective tissue diseases, new drug approvals could help shift the treatment paradigm, according to data presented here.

In this Healio Video Perspective from the AWIR Annual Conference, Janet Pope, MD, professor of medicine, epidemiology and biostatistics at Western Bone and Joint Institute in Ontario, Canada, shares three important points from her session on pulmonary arterial hypertension and interstitial lung disease in scleroderma.

A wide array of potential etiologies can cause lung disease in rheumatoid arthritis patients, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.

Among patients with myositis-associated rapidly progressive interstitial lung disease, extracorporeal membrane oxygenation was well tolerated with no deaths from direct complications, according to a case series published in Chest.

Following the recent approvals of nintedanib and tocilizumab for systemic sclerosis-related interstitial lung disease, providers should manage the disease based on severity, progression risk and extrapulmonary activity, noted researchers.

The Healio Editors have compiled a list of the most-read news in pulmonology posted in July.

Rheumatoid arthritis-related interstitial lung disease was associated with significantly higher rates of excess mortality compared with the general population, according to new research published in BMC Pulmonary Medicine.

Higher circulating levels of the protein CTRP9 are associated with worse lung function in patients with systemic sclerosis-related interstitial lung disease, according to data published in Arthritis Care & Research.